A volcanic explosion of autoantibodies in systemic lupus erythematosus: A diversity of 180 different antibodies found in SLE patients

Autoimmunity Reviews

Volumn 14, Issue 1, 2015, Pages 75-79

  Yaniv, Gal ^a   Twig, Gilad ^a,d   Shor, Dana Ben Ami ^a   Furer, Ariel ^d   Sherer, Yaniv ^a,b,c   Mozes, Oshry ^a   Komisar, Orna ^a   Slonimsky, Einat ^a   Klang, Eyal ^a   Lotan, Eyal ^a   Welt, Mike ^a   Marai, Ibrahim ^e   Shina, Avi ^a   Amital, Howard ^a,b   Shoenfeld, Yehuda ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^d MEDICAL CORPS   (Israel)

^e RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Autoantibodies; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; CELL NUCLEUS ANTIGEN; CYTOPLASMIC ANTIGEN; MATRIX PROTEIN; MEMBRANE ANTIGEN; MISCELLANEOUS ANTIGEN; NERVOUS SYSTEM ANTIGEN; PHOSPHOLIPID ASSOCIATED ANTIGEN; PLASMA PROTEIN; UNCLASSIFIED DRUG; AUTOANTIGEN;

APOPTOSIS; B LYMPHOCYTE ACTIVATION; BLOOD CELL; DISEASE ACTIVITY; DISEASE EXACERBATION; ENDOTHELIUM CELL; HUMAN; PATHOGENESIS; PREVALENCE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; IMMUNOLOGY;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 84922935228     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2014.10.003     Document Type: Review

References (43)

1. Mosca M., Tani C., Aringer M., Bombardieri S., Boumpas D., Cervera R., et al. Development of quality indicators to evaluate the monitoring of SLE patients in routine clinical practice. Autoimmun Rev 2011 May, 10(7):383-388.
2. Arbuckle M.R., McClain M.T., Rubertone M.V., Scofield R.H., Dennis G.J., James J.A., et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003 Oct 16, 349(16):1526-1533.
3. Agmon-Levin N., Mosca M., Petri M., Shoenfeld Y. Systemic lupus erythematosus one disease or many?. Autoimmun Rev 2012 Jun, 11(8):593-595.
4. Shoenfeld Y., Twig G., Katz U., Sherer Y. Autoantibody explosion in antiphospholipid syndrome. J Autoimmun 2008, 30(1-2):74-83.
5. Shoenfeld Y., Gilburd B., Abu-Shakra M., Amital H., Barzilai O., Berkun Y., et al. The mosaic of autoimmunity: genetic factors involved in autoimmune diseases-2008. Isr Med Assoc J 2008 Jan, 10(1):3-7.
6. Sherer Y., Gorstein A., Fritzler M.J., Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 2004 Oct, 34(2):501-537.
7. Rekvig O.P., Putterman C., Casu C., Gao H.X., Ghirardello A., Mortensen E.S., et al. Autoantibodies in lupus: culprits or passive bystanders?. Autoimmun Rev 2012 Jun, 11(8):596-603.
8. Tobon G.J., Youinou P., Saraux A. The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. J Autoimmun 2010 Aug, 35(1):10-14.
9. Wootla B., Lacroix-Desmazes S., Warrington A.E., Bieber A.J., Kaveri S.V., Rodriguez M. Autoantibodies with enzymatic properties in human autoimmune diseases. J Autoimmun 2011 Sep, 37(2):144-150.
10. Fauchais A.L., Martel C., Gondran G., Lambert M., Launay D., Jauberteau M.O., et al. Immunological profile in primary Sjogren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease. Autoimmun Rev 2010 Jul, 9(9):595-599.
11. Munoz L.E., Gaipl U.S., Herrmann M. Predictive value of anti-dsDNA autoantibodies: importance of the assay. Autoimmun Rev 2008 Sep, 7(8):594-597.
12. Wichmann I., Respaldiza N., Garcia-Lozano J.R., Montes M., Sanchez-Roman J., Nunez-Roldan A. Autoantibodies to DEK oncoprotein in systemic lupus erythematosus (SLE). Clin Exp Immunol 2000 Mar, 119(3):530-532.
13. Tsokos G.C. Systemic lupus erythematosus. N Engl J Med 2011 Dec, 365(22):2110-2121.
14. Chen M., Zhao M.H., Zhang Y., Wang H. Antineutrophil autoantibodies and their target antigens in systemic lupus erythematosus. Lupus 2004, 13(8):584-589.
15. Miyawaki S., Nishiyama S., Aita T., Yoshinaga Y. The effect of methotrexate on improving serological abnormalities of patients with systemic lupus erythematosus. Mod Rheumatol 2013 Jul, 23(4):659-666.
16. Buyon J.P., Winchester R. Congenital complete heart block. A human model of passively acquired autoimmune injury. Arthritis Rheum 1990 May, 33(5):609-614.
17. Rothfield N.F., Stollar B.D. The relation of immunoglobulin class, pattern of anti-nuclear antibody, and complement-fixing antibodies to DNA in sera from patients with systemic lupus erythematosus. J Clin Invest 1967 Nov, 46(11):1785-1794.
18. Winfield J.B., Brunner C.M., Koffler D. Serologic studies in patients with systemic lupus erythematosus and central nervous system dysfunction. Arthritis Rheum 1978 Apr, 21(3):289-294.
19. Raz E., Brezis M., Rosenmann E., Eilat D. Anti-DNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney. J Immunol 1989 May, 142(9):3076-3082.
20. Amital H., Heilweil M., Ulmansky R., Szafer F., Bar-Tana R., Morel L., et al. Treatment with a laminin-derived peptide suppresses lupus nephritis. J Immunol 2005 Oct, 175(8):5516-5523.
21. Amital H., Heilweil-Harel M., Ulmansky R., Harlev M., Toubi E., Hershko A., et al. Antibodies against the VRT101 laminin epitope correlate with human SLE disease activity and can be removed by extracorporeal immunoadsorption. Rheumatology (Oxford) 2007 Sep, 46(9):1433-1437.
22. Renaudineau Y., Deocharan B., Jousse S., Renaudineau E., Putterman C., Youinou P. Anti-alpha-actinin antibodies: a new marker of lupus nephritis. Autoimmun Rev 2007 Aug, 6(7):464-468.
23. Kowal C., Degiorgio L.A., Lee J.Y., Edgar M.A., Huerta P.T., Volpe B.T., et al. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci U S A 2006 Dec, 103(52):19854-19859.
24. Lee J.Y., Huerta P.T., Zhang J., Kowal C., Bertini E., Volpe B.T., et al. Neurotoxic autoantibodies mediate congenital cortical impairment of offspring in maternal lupus. Nat Med 2009 Jan, 15(1):91-96.
25. Reichlin M. Cellular dysfunction induced by penetration of autoantibodies into living cells: cellular damage and dysfunction mediated by antibodies to dsDNA and ribosomal P proteins. J Autoimmun 1998 Oct, 11(5):557-561.
26. Shoenfeld Y. To smell autoimmunity: anti-P-ribosomal autoantibodies, depression, and the olfactory system. J Autoimmun 2007, 28(2-3):165-169.
27. Sun K.H., Tang S.J., Chen C.Y., Lee T.P., Feng C.K., Yu C.L., et al. Monoclonal ribosomal P autoantibody inhibits the expression and release of IL-12, TNF-alpha and iNOS in activated RAW macrophage cell line. J Autoimmun 2005 Mar, 24(2):135-143.
28. Zandman-Goddard G., Chapman J., Shoenfeld Y. Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin Arthritis Rheum 2007 Apr, 36(5):297-315.
29. Katzav A., Solodeev I., Brodsky O., Chapman J., Pick C.G., Blank M., et al. Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arthritis Rheum 2007 Mar, 56(3):938-948.
30. Blank M., Cohen J., Toder V., Shoenfeld Y. Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci U S A 1991 Apr, 88(8):3069-3073.
31. To C.H., Petri M. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?. Arthritis Rheum 2005 Dec, 52(12):4003-4010.
32. Gualtierotti R., Biggioggero M., Penatti A.E., Meroni P.L. Updating on the pathogenesis of systemic lupus erythematosus. Autoimmun Rev 2010 Nov, 10(1):3-7.
33. DeGiorgio L.A., Konstantinov K.N., Lee S.C., Hardin J.A., Volpe B.T., Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001 Nov, 7(11):1189-1193.
34. Lapteva L., Nowak M., Yarboro C.H., Takada K., Roebuck-Spencer T., Weickert T., et al. Anti-N-methyl-d-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis Rheum 2006 Aug, 54(8):2505-2514.
35. Hanly J.G., Harrison M.J. Management of neuropsychiatric lupus. Best Pract Res Clin Rheumatol 2005 Oct, 19(5):799-821.
36. Katsumata Y., Harigai M., Kawaguchi Y., Fukasawa C., Soejima M., Kanno T., et al. Diagnostic reliability of magnetic resonance imaging for central nervous system syndromes in systemic lupus erythematosus: a prospective cohort study. BMC Musculoskelet Disord 2010, 11:13.
37. Sibbitt W.L., Sibbitt R.R., Brooks W.M. Neuroimaging in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 1999 Oct, 42(10):2026-2038.
38. Huizinga T.W., Steens S.C., van Buchem M.A. Imaging modalities in central nervous system systemic lupus erythematosus. Curr Opin Rheumatol 2001 Sep, 13(5):383-388.
39. Appenzeller S., Pike G.B., Clarke A.E. Magnetic resonance imaging in the evaluation of central nervous system manifestations in systemic lupus erythematosus. Clin Rev Allergy Immunol 2008 Jun, 34(3):361-366.
40. Castellino G., Govoni M., Giacuzzo S., Trotta F. Optimizing clinical monitoring of central nervous system involvement in SLE. Autoimmun Rev 2008 Feb, 7(4):297-304.
41. Sanna G., Piga M., Terryberry J.W., Peltz M.T., Giagheddu S., Satta L., et al. Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations. Lupus 2000, 9(8):573-583.
42. Csepany T., Bereczki D., Kollar J., Sikula J., Kiss E., Csiba L. MRI findings in central nervous system systemic lupus erythematosus are associated with immunoserological parameters and hypertension. J Neurol 2003 Nov, 250(11):1348-1354.
43. Kumral E., Evyapan D., Keser G., Kabasakal Y., Oksel F., Aksu K., et al. Detection of microembolic signals in patients with neuropsychiatric lupus erythematosus. Eur Neurol 2002, 47(3):131-135.